NCT01837056

Brief Summary

Investigate the prevalence of Toxoplasma gondii and Toxocara canis in Uveitis

  • serum antibody to T. gondii and T. canis
  • PCR with peripheral blood for T. gondii and T. canis
  • PCR with aqueous humor for T. gondii and T. canis
  • Clinical manifestation of patient with uveitis

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2011

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 12, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 22, 2013

Completed
Last Updated

April 22, 2013

Status Verified

April 1, 2013

Enrollment Period

1.1 years

First QC Date

April 12, 2013

Last Update Submit

April 17, 2013

Conditions

Uveitis

Keywords

Toxoplasma gondiiToxocara canis

Outcome Measures

Primary Outcomes (1)

  • Number of patients with positive result for serum antibody to Toxoplasma gondii and Toxocara canis

    proportion of patients with seropositive for Toxoplasma gondii and Toxocara canis among patients

    at baseline

Secondary Outcomes (1)

  • Number of patients with positive PCR with peripheral blood and aqueous humor to Toxoplasma gondii and Toxocara canis

    at baseline

Other Outcomes (2)

  • location of inflammation and fundus finding

    at baseline

  • Demographic characteristics

    at baseline

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patient with uveitis

You may qualify if:

  • patients with uveitis

You may not qualify if:

  • Patients with history of major ophthalmic surgery within 6 months
  • antiviral, antifungal or antiparasitic therapy within 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Uveitis

Condition Hierarchy (Ancestors)

Uveal DiseasesEye Diseases

Study Officials

  • Su Jin Lim, MD

    Nune Eye Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
14 Days
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The retina staff

Study Record Dates

First Submitted

April 12, 2013

First Posted

April 22, 2013

Study Start

January 1, 2011

Primary Completion

February 1, 2012

Study Completion

February 1, 2012

Last Updated

April 22, 2013

Record last verified: 2013-04